Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L37 pseudogene 21 (RPL37P21) is a processed pseudogene related to the functional gene encoding ribosomal protein L37, a component of the large (60S) ribosomal subunit that participates in protein synthesis[2][13]. As a pseudogene, RPL37P21 does not encode a functional protein and is generally not expressed or studied as a therapeutic target. It is one of numerous ribosomal protein pseudogenes annotated in the human genome[10][13]. There is no evidence indicating that this pseudogene has a biological function, disease involvement, or pharmacological relevance. RPL37P21 is not a therapeutic target such as a receptor, enzyme, or transporter[13][10]. It lacks known biological functions and disease associations, in contrast to its parent gene (RPL37), which encodes an essential ribosomal protein[5][7][12]. No drugs, biomarker use, or safety concerns are linked to this pseudogene[2][13][11]. It is not incorrect as a gene symbol, but is not appropriate for therapeutic targeting purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L37 pseudogene 21 (RPL37P21).